SynthesisThe oncologist2025

Exploring the impact of first-line durvalumab plus chemotherapy on advanced biliary tract cancer: a systematic review and meta-analysis.

Patrick Reimann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.